Arrhythmias & electrophysiology
Real-world utilization of the pill-in-the-pocket method for terminating episodes of atrial fibrillation: data from the multinational Antiarrhythmic Interventions for Managing Atrial Fibrillation (AIM-AF) survey
Authors' conclusion
Our findings highlight the frequent use of PITP
Study context
- Population
- Clinicians (cardiologists and electrophysiologists) managing atrial fibrillation (AF) in the US and Europe
- Exposure
- Pill-in-the-pocket (PITP) use stratified by US vs European countries and by cardiologists vs electrophysiologists
- Outcome
- Current pill-in-the-pocket (PITP) usage for terminating AF episodes
Methodological detailssurvey, multinational, planned sub-study of the AIM-AF survey
- Survey
- Multinational
- Planned sub-study of the AIM-AF survey
Main finding
As reported in the abstract
PITP usage
- Clinicians in both the USA and Europe consider PITP in about a quarter of their patients, mostly for recent-onset AF with minimal or no structural heart disease (guideline appropriate)
- Significant deviations from guideline-appropriate use exist
Observational data: associations, not effects.
Original publication
Real-world utilization of the pill-in-the-pocket method for terminating episodes of atrial fibrillation: data from the multinational Antiarrhythmic Interventions for Managing Atrial Fibrillation (AIM-AF) survey. Europace. Published 24 June 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →